can i go from tirzepatide to semaglutide vs. Semaglutide: What You Should Know Semaglutide vs. Tirzepatide vs. Retatrutide
Description
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed by Eli Lilly for the treatment of type 2 diabetes and obesity
Colleen McCabe, PharmD, BCOP, and Lindsay Mundy, PharmD, BCOP, provided an engaging exploration of the benefits and potential pitfalls seen with the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in an oncology setting
The truth about GLP-1 weight loss medications and their impact on athletic performance
BMI 28-29: 5 mg
The mixture of pre-, pro- and postbiotics ensures healthy gut health.
NexLife vs Noom Med compared for 2026: pricing ($199/mo vs $145/mo NexLife), v3.0 transparency scoring (70/100 vs 94/100), clinical model
